Obesity Trial, Recruiting (NCT06970457)

Obesity Trial, Recruiting NCT06970457 Sponsor: Oklahoma State University Condition: Obesity

Printed from Voxsanity (voxsanity.com.au) — NCT06970457 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Obesity

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are biologically male
People with a BMI either in the range of 18.5–24.9 kg/m² (considered a "normal" weight range) or 30 kg/m² and above (considered obese)
People with a body fat percentage either below 20% or 25% and above
People who are able and willing to follow a regular exercise program as part of the trial

Who may not be able to join:

People who have a long-term health condition, or who regularly take prescription medications for such a condition, that could significantly affect what the trial is measuring (confirm with trial site)
People who drink alcohol excessively, or who use tobacco, vaping products, or illegal drugs
People who have an electrical device implanted in their body, such as a pacemaker

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 16 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Sam Emerson, PhD, Oklahoma State University

Phone: 4057442303

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06970457

Sponsor: Oklahoma State University

Phase: Not Applicable

Status: Recruiting

Condition: Obesity

Trial contact: 4057442303

More information: https://clinicaltrials.gov/study/NCT06970457

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are biologically male
People with a BMI either in the range of 18.5–24.9 kg/m² (considered a "normal" weight range) or 30 kg/m² and above (considered obese)
People with a body fat percentage either below 20% or 25% and above
People who are able and willing to follow a regular exercise program as part of the trial

Who may not be able to join:

People who have a long-term health condition, or who regularly take prescription medications for such a condition, that could significantly affect what the trial is measuring (confirm with trial site)
People who drink alcohol excessively, or who use tobacco, vaping products, or illegal drugs
People who have an electrical device implanted in their body, such as a pacemaker

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 16 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Oklahoma State University

Registry

ClinicalTrials.gov

Start date

15 April 2025

Est. completion

31 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Fat Mass; Lean mass; Testosterone; Human Growth Hormone; Estradiol; SHBG; Luteinizing Hormone; FSH; Adiponectin; Leptin; Aromatase; Insulin; KISS1; GnRH; Inflammatory Cytokine Panel; Triglycerides; Glucose; HDL-C; Total Cholesterol; Visceral Adipose Tissue

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov